ChromaDex Corporation, Irvine, CA, has entered into a securities purchase agreement with Jinke Group (Hong Kong) Ltd., under which Jinke has agreed to purchase 1,916,811 shares of common stock for a purchase price of $0.5217 per share, which will provide gross proceeds (as well as net proceeds after expenses) to ChromaDex of approximately $1,000,000. As part of the transaction, Jinke is also receiving warrants to purchase an additional 1,333,334 shares of common stock at $0.80 per share.

“We are pleased that Jinke Group has shown such confidence in ChromaDex,” said Frank Jaksch, CEO and co-founder of the company. “The funds from Jinke will provide ChromaDex with additional working capital to support our business expansion plans. We are confident this financing will help position the Company to support the next phase of growth in becoming the premier provider of phytochemical and botanical reference standards to the functional food, cosmetic, dietary supplement, pharmaceutical/life sciences and other industries.”

ChromaDex expects to use the net proceeds to fund organic expansion as well as for general corporate purposes and working capital. Neither the sale nor issuance of the shares of common stock, warrants or the shares of common stock underlying the warrants in this transaction has been registered under the Securities Act of 1933, as amended, or applicable state securities laws and will not be offered, sold or transferred in the U.S. absent registration or an exemption from registration.